San Francisco Bay Area biotech stories.
Wednesday, February 23, 2011
Anthera Q4 loss balloons to $13M on clinical trial costs
Anthera Pharmaceuticals Inc., which went public last year, lost $13 million in the December quarter and $40.4 million for the year as it spent more money on clinical trials.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)